Insights

WCG is dedicated to helping provide insights, leadership, and guidance to the clinical research industry during this global healthcare crisis.

Viewing all entries for: COVID-19

Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Read More about Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Part 9: The Challenges of Developing Vaccines and Treatments for COVID-19

Read More about Part 9: The Challenges of Developing Vaccines and Treatments for COVID-19

PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects

Read More about PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects

COVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up

Read More about COVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up

PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Read More about PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Part 8: The Realities of Restart

Read More about Part 8: The Realities of Restart

Part 7: Imagining the Future State of Clinical Research

Read More about Part 7: Imagining the Future State of Clinical Research

Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting

Read More about Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting

Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes

Read More about Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes

Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research

Read More about Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research